[Federal Register Volume 80, Number 56 (Tuesday, March 24, 2015)]
[Notices]
[Page 15653]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-06795]



[[Page 15653]]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[File No. 500-1]


In the Matter of First China Pharmaceutical Group, Inc.; Order of 
Suspension of Trading

March 20, 2015.
    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
First China Pharmaceutical Group, Inc. because it has not filed any 
periodic reports since the period ended September 30, 2012.
    The Commission is of the opinion that the public interest and the 
protection of investors require a suspension of trading in the 
securities of the above-listed company. Therefore, it is ordered, 
pursuant to Section 12(k) of the Securities Exchange Act of 1934, that 
trading in the securities of the above-listed company is suspended for 
the period from 9:30 a.m. EDT on March 20, 2015, through 11:59 p.m. EDT 
on April 2, 2015.

    By the Commission.
Jill M. Peterson,
Assistant Secretary.
[FR Doc. 2015-06795 Filed 3-20-15; 11:15 am]
BILLING CODE 8011-01-P